EUVIMEDObjevte EUVIMED
Crossref

Discovery of natural multi‐targets neuraminidase inhibitor glycosides compounds against influenza A virus through network pharmacology, virtual screening, molecular dynamics simulation, and in vitro experiment

Luxi Cao, Yaru Liu, Bei Ma, Bingxiang Yi, Jiaying Sun

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14359 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2024. Written by Luxi Cao and 4 co-authors. Institution: School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China. Major MEDLINE topics: Influenza A virus, Drugs, Chinese Herbal. Cited 6 times so far (Crossref); 39 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Influenza virus continually challenges both human and animal health. Moreover, influenza viruses are easy to mutate. In a certain degree, vaccines may not catch up with rapid mutant paces of viruses. Anti‐influenza drugs NIs (neuraminidase inhibitors) are one of the best choices. Therefore, based on ADMET properties, eight optimal natural multi‐targets NIs glycosides compounds (IC 50 = 0.094–97.275 μM) are found from radix glycyrrhizae, flos sophorae, caulis spatholobi, radix astragali, radix glycyrrhizae, semen astragali complanati , and common fenugreek seed through network pharmacology, molecular docking, dynamics simulation, quantum chemistry, and in vitro experiment. Moreover, mechanism research illustrates these natural compounds treat influenza A virus through key targets TLR4, TNF, and IL6 (high fever, acute respiratory distress syndrome), MAPK1, and MAPK3 (MAPK signaling pathway, viral RNP export, and viral protein expression), IL1B (NOD‐like receptor signaling pathway, suppressed maturation of pro‐IL‐1β and pro‐IL‐18), CASP3 (apoptosis), AKT1 (inhibited premature apoptosis), and EP300 (viral myocarditis, chemoattraction of monocytes and macrophages, T‐cell activation antibody response).

Subjects

MeSH terms (MEDLINE)

Influenza A virusDrugs, Chinese HerbalAnimalsHumansNeuraminidaseMolecular Dynamics SimulationNetwork PharmacologyMolecular Docking SimulationAntiviral AgentsEnzyme Inhibitors

Author keywords

influenzamechanism researchmulti-targetsnetwork pharmacologyneuraminidase inhibitorsvirtual screening

Substances

NeuraminidaseAntiviral AgentsEnzyme InhibitorsDrugs, Chinese Herbal

Authors and institutions

  • School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China.
  • Key Laboratory of Screening and Activity Evaluation of Targeted Drugs, Chongqing, China.

Cite

APA

Cao, L., Liu, Y., Ma, B., Yi, B., & Sun, J. (2024). Discovery of natural multi‐targets neuraminidase inhibitor glycosides compounds against influenza A virus through network pharmacology, virtual screening, molecular dynamics simulation, and in vitro experiment. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14359

Vancouver

Cao L, Liu Y, Ma B, Yi B, Sun J. Discovery of natural multi‐targets neuraminidase inhibitor glycosides compounds against influenza A virus through network pharmacology, virtual screening, molecular dynamics simulation, and in vitro experiment. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14359

BibTeX
@article{Cao2024,
  author = {Cao, Luxi and Liu, Yaru and Ma, Bei and Yi, Bingxiang and Sun, Jiaying},
  title = {Discovery of natural multi‐targets neuraminidase inhibitor glycosides compounds against influenza A virus through network pharmacology, virtual screening, molecular dynamics simulation, and in vitro experiment},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14359}
}
Start for free →